Shingrix Vaccine: Safety in Psoriasis and Psoriatic Arthritis

We are studying the safety and immune response of the Shingrix vaccine in patients with psoriasis or psoriatic arthritis. Our goal is to see how the vaccine affects disease activity and to monitor any side effects.

>2 years Monitoring phase (IV)No Placebo Partially Remote Standard Medicines InjectionAllergologyDermatology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Shingrix

Shingrix is a vaccine used to prevent shingles, the painful rash that can occur in adults who had chickenpox.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

3-O-Desacyl-4'-Monophosphoryl Lipid A

3-O-Desacyl-4'-Monophosphoryl Lipid A is a vaccine adjuvant that helps strengthen the body's immune response to vaccines.

Recombinant Varicella Zoster Virus Glycoprotein E

Recombinant Varicella Zoster Virus Glycoprotein E is a substance that helps prevent shingles by stimulating the immune system.

Stimulon

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Thermalsole und Schwefelbad Bentheim GmbH

Clinical Study Center

Bad Bentheim, Germany

Goethe University Frankfurt

Clinic for Dermatology, Venereology and Allergology - clinical reserach

Frankfurt am Main, Germany

Medical Center - University Of Freiburg

Department of Rheumatology and Clinical Immunology

Freiburg, Germany

Sponsor: Justus-Liebig-Universitaet Giessen

Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.